Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xuanbai Shengmai Decoction in ARDS
NCT07528196Phase 3Not yet recruiting
- Sponsor
- Southeast University
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Modality
- TCM (Traditional Chinese Medicine)
01
Overview
A Phase 3 trial of Xuanbai Shengmai Decoction in acute respiratory distress syndrome (ARDS), sponsored by Southeast University. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
Xuanbai Shengmai Decoction
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT07528196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07528196.